Palisade Asset Management LLC lowered its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 7.7% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 73,704 shares of the healthcare conglomerate’s stock after selling 6,152 shares during the quarter. UnitedHealth Group accounts for about 2.6% of Palisade Asset Management LLC’s investment portfolio, making the stock its 6th biggest holding. Palisade Asset Management LLC’s holdings in UnitedHealth Group were worth $27,055,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds also recently bought and sold shares of UNH. Nvwm LLC boosted its position in UnitedHealth Group by 89.2% in the third quarter. Nvwm LLC now owns 70 shares of the healthcare conglomerate’s stock worth $26,000 after purchasing an additional 33 shares during the last quarter. Wellington Altus USA Inc. increased its position in shares of UnitedHealth Group by 97.1% during the 2nd quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 33 shares during the last quarter. Security National Bank of SO Dak bought a new position in shares of UnitedHealth Group in the 2nd quarter worth approximately $29,000. Compass Wealth Management LLC bought a new position in shares of UnitedHealth Group in the 3rd quarter worth approximately $29,000. Finally, Aberdeen Wealth Management LLC purchased a new position in shares of UnitedHealth Group in the second quarter worth approximately $31,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.
UnitedHealth Group News Summary
Here are the key news stories impacting UnitedHealth Group this week:
- Positive Sentiment: ETFs purchased $56.4 million of UNH shares on Nov. 4, a potentially supportive demand signal. ETFs Are Buying UnitedHealth (UNH) on Nov. 4
- Positive Sentiment: UnitedHealth’s Q3 adjusted EPS of $4.69 topped analyst expectations, and a recent earnings analysis said the results bolstered confidence in a margin recovery. UnitedHealth (UNH) Q3 Earnings Lift Confidence In Margin Recovery
- Positive Sentiment: A Zacks article characterized Wall Street analysts’ view of UNH as a Buy, offering a favorable sentiment signal, though the article summary did not cite a specific new rating change. Wall Street Analysts See UnitedHealth (UNH) as a Buy: Should You Invest?
- Positive Sentiment: The company declared a quarterly dividend of $2.32 per share, equivalent to $9.28 annually and a reported yield of 2.3%. UnitedHealth Group Declares Quarterly Dividend Of $2.32 Per Share
- Negative Sentiment: Utilization and policy concerns remain an overhang for the company, highlighting uncertainty around medical costs and the regulatory environment. Utilization and Policy Concerns Weigh on UnitedHealth Group Incorporated (UNH)
- Negative Sentiment: Renewed calls for a regulatory review of UnitedHealth’s business scale, alongside warnings that AI could disrupt large healthcare companies, add longer-term risk concerns. UnitedHealth Group (UNH) Draws Breakup Pressure As AI Threat Enters The Story
Insider Buying and Selling at UnitedHealth Group
In related news, CEO Patrick Conway sold 1,169 shares of the company’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This represents a 7.09% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 0.19% of the company’s stock.
Wall Street Analyst Weigh In
Several analysts recently issued reports on the stock. TD Cowen restated a “hold” rating and set a $402.00 target price on shares of UnitedHealth Group in a research report on Thursday, October 15th. Weiss Ratings upgraded shares of UnitedHealth Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, October 8th. Zacks Research downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 14th. Mizuho upped their price objective on UnitedHealth Group from $493.00 to $500.00 and gave the stock an “outperform” rating in a research note on Thursday, October 22nd. Finally, Sanford C. Bernstein decreased their target price on UnitedHealth Group from $512.00 to $500.00 and set an “outperform” rating on the stock in a report on Wednesday, October 14th. Twenty analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average target price of $463.93.
View Our Latest Research Report on UnitedHealth Group
UnitedHealth Group Trading Down 0.4%
UnitedHealth Group stock opened at $394.14 on Friday. UnitedHealth Group Incorporated has a 12-month low of $255.96 and a 12-month high of $461.62. The firm has a market capitalization of $353.16 billion, a price-to-earnings ratio of 22.51, a P/E/G ratio of 1.43 and a beta of 0.51. The firm has a 50 day moving average of $390.62 and a 200 day moving average of $364.03. The company has a current ratio of 0.74, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, beating the consensus estimate of $4.14 by $0.55. The business had revenue of $112.72 billion for the quarter, compared to the consensus estimate of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The company’s revenue for the quarter was down .4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, research analysts predict that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th will be given a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a dividend yield of 2.4%. The ex-dividend date is Monday, December 7th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 53.00%.
About UnitedHealth Group
UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid.
Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.
Founded in 1977 as United HealthCare Corporation, the company is headquartered in Minnetonka, Minnesota.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
